⌘K
Loading ticker…
Rezolute, Inc. Common Stock (NV) · Healthcare · Pharmaceutical Products
As of 2026-06-26, Rezolute, Inc. Common Stock (NV) (RZLT) has a 3-month relative strength percentile of 91 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 61. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 9.3%, relative volume 2.76×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 91, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
RZLT is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $8M notional. Top 3 carry $16M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $8M |
| IWMiShares Russell 2000 ETF | 0.01% | $5M |
| VXFVanguard Extended Market ETF | 0.00% | $3M |
| IWOiShares Russell 2000 Growth ETF | 0.01% | $2M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $357K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RZLT Jan avg: 20.91% median: 17.49% win: 100% σ: 15.56% n: 4 2022-04-12 → 2026-05-29 | RZLT Feb avg: 6.75% median: -3.70% win: 25% σ: 29.38% n: 4 2022-04-12 → 2026-05-29 | RZLT Mar avg: -1.89% median: -13.78% win: 25% σ: 39.53% n: 4 2022-04-12 → 2026-05-29 | RZLT Apr avg: 10.47% median: 5.10% win: 100% σ: 10.86% n: 5 2022-04-12 → 2026-05-29 | RZLT May avg: 7.78% median: 3.13% win: 80% σ: 27.54% n: 5 2022-04-12 → 2026-05-29 | RZLT Jun avg: 5.82% median: 7.48% win: 75% σ: 9.37% n: 4 2022-04-12 → 2026-05-29 (current) | RZLT Jul avg: 7.90% median: 1.88% win: 50% σ: 17.83% n: 4 2022-04-12 → 2026-05-29 | RZLT Aug avg: -5.92% median: -9.70% win: 50% σ: 21.31% n: 4 2022-04-12 → 2026-05-29 | RZLT Sep avg: 10.18% median: 8.51% win: 75% σ: 17.45% n: 4 2022-04-12 → 2026-05-29 | RZLT Oct avg: -13.55% median: -14.44% win: 25% σ: 23.73% n: 4 2022-04-12 → 2026-05-29 | RZLT Nov avg: -6.21% median: -5.20% win: 25% σ: 9.75% n: 4 2022-04-12 → 2026-05-29 | RZLT Dec avg: -6.12% median: 11.34% win: 50% σ: 48.49% n: 4 2022-04-12 → 2026-05-29 |